Results

Total Results: 1,134 records

Showing results for "days".

341. Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 3 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3_0.pdf
     May 01, 2022 - C Campbell, 2018 Moderate A: Self-reported frequent cannabis use of ≥20 days/mo B: No cannabis

342. Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final_0_0.pdf
     March 01, 2022 - C Campbell, 2018 Moderate A: Self-reported frequent cannabis use of ≥20 days/mo B: No cannabis

343. Disposition of Comments for CER 202 Effectiveness and Safety of Bronchial Thermoplasty in the Management of Asthma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-202-thermoplasty-comments.pdf
     December 14, 2017 - statistically significant reductions in such utilization measures as ED visits, hospitalizations, and days … As reported in AIR2 (Castro 2010), post procedure, BT patients experienced only ~1.3 days lost from … work related to asthma; while AIR2 sham patients lost ~3.9 days from work post-procedure (99.3% PPS … We are aware that Castro 2010 reports this difference in days lost from work, but the result is only … Moreover, this same trial notes improvements in asthma control as evidenced by reductions in days lost

344. Disposition of Comments for CER 201 Effectiveness of Indoor Allergen Reduction in the Management of Asthma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-201-indoor-allergen-asthma-disposition-comments.pdf
     February 15, 2018 - Outcome measures included symptom-free asthma days as reported by parents, parental sleep interruption … , degree to which child was bothered by asthma symptoms, and the number of days child was Thank you … Although symptom days are often used as a primary outcome in published studies, they do not represent … that in studies that enroll low-income urban populations, the most commonly used primary outcome is days … Although symptom days are often used as a primary outcome in published studies, they do not represent

345. App-E-Surv-Report-1-Nonopioid-Pharmacol-Chronic-Pain (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
     May 29, 2025 - NPP Table E-1. Neuropathic pain study characteristics Author, Year Country Trial Type Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed Intervention Duration (Weeks) Funding Source Hussain, 2021 Pakistan Placebo-controlled Fair NPP (DPN) Age, mean: 45 Female: 0% R…

346. Traumatic-Brain-Injury-Rehabilitation Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/traumatic-brain-injury-rehabilitation_research-protocol.pdf
     October 25, 2010 - Mental State* A moment to 24 hours >24 hours >24 hours Post-traumatic Amnesia 0–1 day >1 and <7 days … >7 days Glasgow Coma Scale (best available score in 24 hours) 13–15 9–12 3–8 Abbreviated Injury

347. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - topiramate and mid-titration (maintenance) daily dosage of 7.5 mg phentermine and 46 mg topiramate for 30 days

348. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/telehealth_disposition-comments.pdf
     June 30, 2016 - patients with chronic conditions • Provided care for 144,520 veterans • 59% reduction in bed days … 278,000 encounters to 91,000 patients • 1.1 million patient encounters since FY2003 • Reduced bed days … reduction in emergency admissions, a 14% reduction in elective admissions, a 14% reduction in bed days … average number of hospitalizations decreased 42%, from 3.3 to 1.9 admissions, the average number of days … hospitalized decreased 64%, from 14.2 to 5.2 days, and the average total charges decreased 67%,

349. Mrsa-Screening-2010 Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mrsa-screening-2010_executive.pdf
     January 01, 2010 - screening using a testing modality with intermediate turnaround (results available next day to 2 days … testing modality (typically culture) with a longer turnaround time (results available more than 2 days … significant increase in rates of MRSA infection with screening surgical patients (1.11/1,000 patient days … vs. 0.91/1,000 patient days). … pre, 0.63/1,000 patient days post; p=0.003).

350. Machine Learning Methods in Systematic Reviews: Identifying Quality Improvement Intervention Evaluations (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/machine-learning-quality_research.pdf
     September 01, 2012 - increased length of hospital stay compared with patients who did not receive hospitalist care (6.0 days … vs. 5.2 days; P = .13). … Time blocks of 4 hours were randomized over 8 intensive care units and the 7 days of the week. … less for the intervention group, and the intervention group had a shorter length of treatment (6 days … ) than the control group (10 days).

351. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - topiramate and mid-titration (maintenance) daily dose of 7.5 mg phentermine and 46 mg topiramate for 30 days

352. Evidence Summary: Comparative Effectiveness Review No. 236 Maternal, Fetal, and Child Outcomes of Mental Health Treatments in Women: A Systematic Review of Perinatal Pharmacologic Interventions (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-236-mental-health-pregnancy-evidence-summary.pdf
     April 01, 2021 - postpartum is associated with improved depressive symptoms shortly after infusion (60 hours) and at 30 days

353. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - support program to facilitate access to nintedanib; it features nurse-support access 24 hours a day, 7 days … It features nurse access 24 hours a day, 7 days a week, financial- support resources, and educational … Median time to extubation and hospital length of stay were 2 days (range 1–99) and 23 days (range 7 … hands-on clinical training for the OCS Lung was $100,000, and clinical field support 24 hours a day, 7 days … Employees of the three centers reportedly received 2 days of training on the XPS.120 Clinical Pathway

354. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1306.pdf
     October 01, 2014 - mg of mifepristone is being administered orally, in four 300 mg tablets, once daily, for several days … the efficacy ‘signal.’ ”6 In “Study 14,” it is testing a 1,200 mg, once-daily dosage given for 7 days … depressive symptoms improved both significantly and rapidly and that these effects lasted from 3 days … midazolam, showed an 8.8 point decrease.35 This statistically significant superiority was maintained 7 days

355. Since their introduction in 20xx, DES have been shown in clinical trials to decrease TLR (… (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-stents-outcomes_research.pdf
     January 01, 2010 - Mean follow-up for BMS patients was slightly longer (496 ± 371 days) than for DES patients (456 ± 302 … days) due to the trends in stent use over the time period studied. … 21.0%) <0.001 32.0 31.2 NS 2006 84537 (38.8%) 16073 (35.7%) <0.001 38.3 38.5 NS Mean Follow-up (days … Symptom Onset 12-24 hrs 1.010 0.932 1.094 Symptom Onset 24-48 hrs 1.015 0.930 1.107 Symptom Onset 2-7 Days

356. Alcohol-Misuse Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse_research-protocol.pdf
     April 28, 2010 - or changes in other long-term (6 months or longer) outcomes (e.g., health care utilization, sick days … mortality, or changing other long-term (6 months or longer) outcomes (e.g., health care utilization, sick days … Sick days 11. Costs 12. Legal issues 13. Employment stability 14. … Alcohol-related accidents and injuries  Quality of life Other: Health care utilization Sick days

357. Depression-Postpartum-Screening Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-postpartum-screening_executive.pdf
     May 01, 2013 - 1 Comparative Effectiveness Review Number 106 Efficacy and Safety of Screening for Postpartum Depression Executive Summary Background Condition and Preventive Strategies Depression is a potentially life-threatening condition with a substantial impact on quality of life. The impact of depression in postpart…

358. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1306.pdf
     January 01, 2016 - patients would also need access to a highly trained, multidisciplinary care team 24 hours a day, 7 days … The recommended dose for ranibizumab is 0.3 mg (0.05 mL) once monthly (every 28 days) by intravitreal

359. Dietary Total Fat Intake and Dietary Polyunsaturated Fatty Acid Intake and Child Growth and Development Outcomes: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/child-growth-development-outcomes-protocol-amended.pdf
     November 18, 2024 - described by the Developmental Origins of Health and Disease (DOHaD),9-11 and supported by the ‘1st 1000 Days … PMID: 19711246. 12. 1 D. 1,000 Days. https://thousanddays.org/about/. Accessed June 19 2024. 13. … Improving Nutrition in the First 1000 Days in the United States: A Federal Perspective.

360. Binge-Eating Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/binge-eating_executive.pdf
     December 01, 2015 - At least 2 days a week for 6 months (DSM-IV frequency and duration criteria) b. … = 0.024) High for benefit MA of 3 RCTs (N = 122) Antidepressants decreased the frequency of binge days … Patients treated with lisdexamfetamine also experienced a greater reduction in binge-eating days per … receiving placebo: point estimates of the differences in two Phase 3 trials were 1.3 and 1.7 fewer days … studies continue to measure and report binge frequency as both discrete binge episodes and binge days